Vergoeding 2017-2021 voor ATC-subgroep A10BH : Dipeptidylpeptidase-4-remmers

  • Raming voor de totale Zvw-populatie
  2017 2018 2019 2020 2021
A10BH01 Sitagliptine (Januvia ®) 7.499.100 8.041.000 9.659.400 10.544.600 10.395.400
A10BH02 Vildagliptine (Galvus ®) 1.598.900 1.473.800 1.457.200 1.431.000 1.228.700
A10BH03 Saxagliptine (Onglyza ®) 484.410 416.150 391.220 350.210 298.080
A10BH05 Linagliptine (Trajenta ®) 2.364.300 2.479.000 2.905.300 3.279.800 3.244.600
Totaal 11.946.710 12.409.950 14.413.120 15.605.610 15.166.780